Literature DB >> 28820688

The Phenotype of Circulating Neutrophils during Visceral Leishmaniasis.

Smriti Sharma1, Shweta Srivastva1, Richard E Davis2, Siddharth Sankar Singh1, Rajiv Kumar3, Susanne Nylén4, Mary E Wilson5,2,6, Shyam Sundar1.   

Abstract

Visceral leishmaniasis (VL) is a chronic parasitic disease associated with suppressed T cell responses. Although parasites reside intracellularly in macrophages during chronic VL, neutrophils are the first host cell to infiltrate the infection site and phagocytose the parasite. Subsets of neutrophils with unusual characteristics have been documented in human VL, but whether the total neutrophil population is aberrant during disease is not known. Therefore, we examined phenotypic characteristics of unfractionated polymorphonuclear leukocyte (neutrophils) from subjects with active VL, and compared these with neutrophils from healthy controls or subjects who have been treated for VL. The data showed decreased mRNA and diminished amounts of the neutrophil chemoattractant CXCL8 (interleukin [IL]-8), increased IL-10 mRNA and protein, and elevated transcripts encoding arginase-1, which is involved in suppressing T cell responses. Neutrophils from VL subjects showed enhanced capacity to phagocytose Leishmania spp. promastigotes. The results suggest that neutrophils may contribute to immunosuppression in subjects with active VL.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28820688      PMCID: PMC5590568          DOI: 10.4269/ajtmh.16-0722

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

Review 1.  Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival.

Authors:  Norikiyo Ueno; Mary E Wilson
Journal:  Trends Parasitol       Date:  2012-06-21

2.  Oxidant generation by single infected monocytes after short-term fluorescence labeling of a protozoan parasite.

Authors:  Haeok K Chang; Colin Thalhofer; Breck A Duerkop; Joanna S Mehling; Shilpi Verma; Kenneth J Gollob; Roque Almeida; Mary E Wilson
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent.

Authors:  M Boelaert; S El-Safi; A Hailu; M Mukhtar; S Rijal; S Sundar; M Wasunna; A Aseffa; J Mbui; J Menten; P Desjeux; R W Peeling
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-10-22       Impact factor: 2.184

Review 4.  Neutrophils in innate and adaptive immunity.

Authors:  Sébastien Jaillon; Maria Rosaria Galdiero; Davide Del Prete; Marco Antonio Cassatella; Cecilia Garlanda; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-04-04       Impact factor: 9.623

5.  Phenotypic and functional characteristics of HLA-DR+ neutrophils in Brazilians with cutaneous leishmaniasis.

Authors:  Richard E Davis; Smriti Sharma; Jacilara Conceição; Pedro Carneiro; Fernanda Novais; Phillip Scott; Shyam Sundar; Olivia Bacellar; Edgar M Carvalho; Mary E Wilson
Journal:  J Leukoc Biol       Date:  2016-10-17       Impact factor: 4.962

6.  A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis.

Authors:  Smriti Sharma; Richard E Davis; Shweta Srivastva; Susanne Nylén; Shyam Sundar; Mary E Wilson
Journal:  J Infect Dis       Date:  2016-09-06       Impact factor: 5.226

7.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

8.  Differences in human macrophage receptor usage, lysosomal fusion kinetics and survival between logarithmic and metacyclic Leishmania infantum chagasi promastigotes.

Authors:  Norikiyo Ueno; Carol L Bratt; Nilda E Rodriguez; Mary E Wilson
Journal:  Cell Microbiol       Date:  2009-08-20       Impact factor: 3.715

Review 9.  Detection of superoxide anion and hydrogen peroxide production by cellular NADPH oxidases.

Authors:  William M Nauseef
Journal:  Biochim Biophys Acta       Date:  2013-05-07

Review 10.  Diverse novel functions of neutrophils in immunity, inflammation, and beyond.

Authors:  Attila Mócsai
Journal:  J Exp Med       Date:  2013-07-01       Impact factor: 14.307

View more
  5 in total

1.  HLA-DR Class II expression on myeloid and lymphoid cells in relation to HLA-DRB1 as a genetic risk factor for visceral leishmaniasis.

Authors:  Bhawana Singh; Michaela Fakiola; Medhavi Sudarshan; Joyce Oommen; Siddharth Sankar Singh; Shyam Sundar; Jenefer M Blackwell
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

2.  Characterization of the Anti-Inflammatory Capacity of IL-10-Producing Neutrophils in Response to Streptococcus pneumoniae Infection.

Authors:  Liliana A González; Felipe Melo-González; Valentina P Sebastián; Omar P Vallejos; Loreani P Noguera; Isidora D Suazo; Bárbara M Schultz; Andrés H Manosalva; Hernán F Peñaloza; Jorge A Soto; Dane Parker; Claudia A Riedel; Pablo A González; Alexis M Kalergis; Susan M Bueno
Journal:  Front Immunol       Date:  2021-04-28       Impact factor: 8.786

Review 3.  The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Leishmania Infection.

Authors:  Katiuska Passelli; Oaklyne Billion; Fabienne Tacchini-Cottier
Journal:  Front Immunol       Date:  2021-03-01       Impact factor: 7.561

Review 4.  The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis.

Authors:  Suênia da C Gonçalves-de-Albuquerque; Rômulo Pessoa-E-Silva; Lays A M Trajano-Silva; Tayná Correia de Goes; Rayana C S de Morais; Cíntia N da C Oliveira; Virgínia M B de Lorena; Milena de Paiva-Cavalcanti
Journal:  Front Immunol       Date:  2017-10-30       Impact factor: 7.561

5.  An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro.

Authors:  Mareike Ohms; Sonja Möller; Tamás Laskay
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.